# De-escalation of Ticagrelor in Post PPCI

> **NCT05831462** · PHASE1,PHASE2 · UNKNOWN · sponsor: **Assiut University** · enrollment: 400 (estimated)

## Conditions studied

- Ticagrelor

## Interventions

- **DRUG:** Ticagrelor 60mg

## Key facts

- **NCT ID:** NCT05831462
- **Lead sponsor:** Assiut University
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-06-01
- **Primary completion:** 2024-03-31
- **Final completion:** 2024-05-01
- **Target enrollment:** 400 (ESTIMATED)
- **Last updated:** 2023-04-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05831462

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05831462, "De-escalation of Ticagrelor in Post PPCI". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05831462. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*